New York Health Welcomes Board-Certified Family Medicine Physician, Dr. Myrta Isabel Olivera-Dubón

New York Health (NY Health) proudly announces the addition of Dr. Myrta Isabel Olivera-Dubón, a board-certified family medicine physician dedicated to providing comprehensive, evidence-based care. Beginning September 8, 2026, Dr. Olivera-Dubón will be practicing at NY Health’s office located at 1377 5th Ave, Bay Shore, NY 11706. “We are excited to welcome Dr. Olivera-Dubón to our [PR.com]

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C. Wainwright 28 th Annual Global Investment Conference, taking place in New York City September 14-16, 2026.

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System

WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, today announced that its subsidiary, HOPE Therapeutics, Inc. ("HOPE"), will be the first Interventional Psychiatry to deploy Zeta Surgical's newly FDA-cleared Zeta TMS Robotic System, with clinical staff now in training ahead of deployment in Florida.

Abstract Submissions Open for NURSING-2027 in Hamburg, July 12-13, 2027

Abstract submissions are open for NURSING-2027, the 4th International Conference on Nursing and AI-Driven Digital Healthcare, set for July 12–13, 2027, in Hamburg, Germany.

Encision Completes $80,000 Private Placement

(PR-inside.com) BOULDER, CO / ACCESS Newswire / September 11, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced that on September 8, 2026 it completed an $80,000 private placement of common stock with a group of private investors. "We are pleased to have secured necessary funds for general working capital purposes," said Robert Fries, Interim President and CEO of Encision. Pursuant to the securities purchase agreement, the Company issued 2 million common shares at a per share price of $0.04 per common ..

Milan to Host PUBLICHEALTH-2027 on April 19–20, Convening Global Health Stakeholders

PUBLICHEALTH-2027, the 2nd International Conference on Public Health and Health Care System, will take place April 19–20, 2027, in Milan, Italy, gathering global health stakeholders to address emerging public health priorities.

Medical Packaging Films Market: Materials, Applications & Regional Insights

Healthcare packaging is quietly becoming one of the most demanding corners of the materials industry. As drug and device makers push toward smaller, more sensitive, [read full press release...]

McCracken Chiropractic Welcomes New Patients in Calhoun, GA, Offering Drug-Free, Non-Surgical Care for Back Pain, Neck Pain, Sciatica, and Auto Accident Injuries

Optical Outlet Direct Highlights Branded Sunglasses, Professional Eye Care and Australia-Wide Online Shopping from Sydney

Optical Outlet Direct, an independent optical business in Rockdale, Sydney, is highlighting its combination of professional eye care and online access to branded sunglasses.

CTX and P1NP Are the Bone Health Markers That Actually Show What's Happening Right Now

The U.S. FDA grants orphan drug designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for treatment of endogenous Cushing's syndrome

The U.S. FDA has granted Orphan Drug Designation for asedebart (Lu AG13909), Lundbeck's novel investigational anti-ACTH monoclonal antibody, for the treatment of endogenous Cushing's syndrome Endogenous Cushing's Syndrome is a rare endocrine disorder driven in most cases by excess...

Early Bird Registration Extended for the 23rd Annual Sleep Education Consortium (SEC) Conference “From the Womb to the Tomb”

Medical and Dental professionals can register for the 2027 SEC Sleep Conference at the reduced rate. [PR.com]